In this engaging episode, Dr. Faisal Masood Khan, Professor at the University of Calgary, shares his groundbreaking research on predicting leukemia relapse after bone marrow transplantation.
In this insightful discussion, Dr. Khan explores:
- 🔹 The role of biomarkers in accurately predicting leukemia relapse risk.
- 🔹 How Next Generation Sequencing (NGS) is transforming relapse detection.
- 🔹 The life-saving potential of donor lymphocyte infusion (DLI) when applied at the right time.
- 🔹 The impact of translational research on clinical practices in Canada and the UAE.
- 🔹 The future of personalized cancer care through advanced molecular techniques
Dr. Khan emphasizes the importance of precision medicine, early intervention, and interdisciplinary teamwork in shaping the future of leukemia treatment. If you’re passionate about cancer research or healthcare innovation, this conversation offers invaluable insights into improving patient care through cutting-edge technology.
🎥 Watch now to explore how research is revolutionizing cancer care
#mededgemea #LeukemiaRelapse #BoneMarrowTransplant #NGS #Biomarkers #HealthcareInnovation #CancerResearch #PrecisionMedicine #TranslationalResearch #HealthcareLeadership @burjeelholdings @mena_conference
Also Read : AI in Critical Care: Dr. Lama’s Insights on Sepsis, Ethics, and the Future of Healthcare | SCCM
